img
Characterization of Rubidium-Based Nanoparticles by Green Synthesis and Their Effect on Colorectal Cancer Cells      
Yazarlar
Doç. Dr. Dilşad ÖZERKAN Doç. Dr. Dilşad ÖZERKAN
Kastamonu Üniversitesi, Türkiye
İshak Afşin Kariper
Erciyes Üniversitesi, Türkiye
Özet
Objective: Colorectal cancers pose a major threat along with increasing morbidity and mortality to human health worldwide. Therefore, it is crucial to develop effective and safe methods for tumor therapy. In recent years, nanoparticles have emerged as successful candidates for drug delivery into tumor tissues. The particle size of nanoparticles (NPs) is of great importance for passive tumor targeting. Therefore, in this study, we aimed to synthesize and characterize rubidium-based nanoparticles (RbNPs) from the moss Abietinella abietina (AA) and determine their anticancer effects on colorectal carcinoma cell line (HCT116). Materials and Methods: A field emission scanning electron microscope (FESEM), dynamic light scattering (DLS), energy dispersive X-ray analysis (EDX), UV/VIS and fourier transform infrared (FTIR) spectrophotometers were used to characterize the RbNPs. To study the cytotoxicity, a sulforhodamine B (SRB) assay was performed in colorectal carcinoma cell cultures. Results: As a result, RbNPs-AA developed with an average particle size of about 70 nm. RbNPs-AA proved to be cytotoxic at lower doses than free AA, as it decreased cell viability at half the amount of free AA (14.25 µg/mL). Conclusion: The availability of RbNPs, particularly for the treatment of colorectal cancer, is evidenced by the fact that all the data collected are highly relevant.
Anahtar Kelimeler
Colorectal cancer | green synthesis | rubidium nanoparticles
Makale Türü Özgün Makale
Makale Alt Türü ESCI dergilerinde yayımlanan tam makale
Dergi Adı Experimed
Dergi ISSN 2667-5846
Dergi Tarandığı Indeksler TR DİZİN
Makale Dili Türkçe
Basım Tarihi 08-2023
Cilt No 13
Sayı 2
Sayfalar 97 / 102
Doi Numarası 10.26650/experimed.1285692
Makale Linki https://dergipark.org.tr/en/pub/experimed/issue/79893/1285692